These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1851545)

  • 1. Responsiveness of genetically epilepsy-prone rats to aminophylline-induced seizures and interactions with quinolones.
    De Sarro A; De Sarro GB
    Neuropharmacology; 1991 Feb; 30(2):169-76. PubMed ID: 1851545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated treatment with quinolones potentiates the seizures induced by aminophylline in genetically epilepsy-prone rats.
    De Sarro A; Trimarchi GR; Ammendola D; De Sarro G
    Gen Pharmacol; 1992 Sep; 23(5):853-9. PubMed ID: 1426928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Only some anticonvulsants protect against seizures induced by aminophylline in quinolone-treated genetically epilepsy prone rats.
    De Sarro A; Ammendola D; Juliano M; Gareri P; De Sarro G
    Gen Pharmacol; 1993 Nov; 24(6):1393-401. PubMed ID: 8112511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interactions between quinolones and aminophylline in rats genetically predisposed to epilepsy].
    De Sarro A; Trimarchi GR; De Sarro GB
    G Ital Chemioter; 1991; 38(1-3):111-2. PubMed ID: 1365558
    [No Abstract]   [Full Text] [Related]  

  • 5. Electrically evoked potentials in the rat hippocampus slice in the presence of aminophylline alone and in combination with quinolones.
    Dimpfel W; Dalhoff A; Hofmann W; Schlüter G
    Eur Neuropsychopharmacol; 1994 Jun; 4(2):151-6. PubMed ID: 7919945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinolones potentiate cefazolin-induced seizures in DBA/2 mice.
    De Sarro A; Zappalá M; Chimirri A; Grasso S; De Sarro GB
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1497-503. PubMed ID: 8395790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 4-quinolones inhibit biotransformation of caffeine.
    Harder S; Staib AH; Beer C; Papenburg A; Stille W; Shah PM
    Eur J Clin Pharmacol; 1988; 35(6):651-6. PubMed ID: 2853056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between pefloxacin and aminophylline in genetically epilepsy-prone rats.
    Imperatore C; Trimarchi GR; De Sarro A
    J Pharm Pharmacol; 1997 Oct; 49(10):1025-9. PubMed ID: 9364414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and expression of mutational resistance to the 4-quinolone antibacterials.
    Smith JT
    Scand J Infect Dis Suppl; 1986; 49():115-23. PubMed ID: 3547618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of some quinolones on imipenem-induced seizures in DBA/2 mice.
    De Sarro A; Ammendola D; De Sarro G
    Gen Pharmacol; 1994 Mar; 25(2):369-79. PubMed ID: 8026738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Periaqueductal gray neurons exhibit increased responsiveness associated with audiogenic seizures in the genetically epilepsy-prone rat.
    N'Gouemo P; Faingold CL
    Neuroscience; 1998 May; 84(2):619-25. PubMed ID: 9539230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-epileptogenicity relationship of quinolones with special reference to their interaction with gamma-aminobutyric acid receptor sites.
    Akahane K; Sekiguchi M; Une T; Osada Y
    Antimicrob Agents Chemother; 1989 Oct; 33(10):1704-8. PubMed ID: 2556076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in vitro studies with 4-quinolone antimicrobials.
    Felmingham D; O'Hare MD; Robbins MJ; Wall RA; Williams AH; Cremer AW; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1985; 11(5):317-29. PubMed ID: 2941259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinolones, theophylline, and diclofenac interactions with the gamma-aminobutyric acid receptor.
    Segev S; Rehavi M; Rubinstein E
    Antimicrob Agents Chemother; 1988 Nov; 32(11):1624-6. PubMed ID: 2855295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative antimicrobial activity of enoxacin, ciprofloxacin, amifloxacin, norfloxacin and ofloxacin against 177 bacterial isolates.
    Bassey CM; Baltch AL; Smith RP
    J Antimicrob Chemother; 1986 May; 17(5):623-8. PubMed ID: 2941401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective in-vitro inhibition of hepatic oxidative metabolism by quinolones: 7-ethoxyresorufin and caffeine as model substrates.
    Valero F; de la Torre R; Segura J
    J Pharm Pharmacol; 1991 Jan; 43(1):17-21. PubMed ID: 1676053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The comparative in-vitro activity of eight newer quinolones and nalidixic acid.
    King A; Phillips I
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():1-20. PubMed ID: 3468100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminophylline exhibits convulsant action in rats during ontogenesis.
    Mares P; Kubová H; Czuczwar SJ
    Brain Dev; 1994; 16(4):296-300. PubMed ID: 7818024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced and photoinduced DNA damage by quinolones: ciprofloxacin, ofloxacin and nalidixic acid determined by comet assay.
    Sánchez G; Hidalgo ME; Vivanco JM; Escobar J
    Photochem Photobiol; 2005; 81(4):819-22. PubMed ID: 15691228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexmedetomidine decreases seizure threshold in a rat model of experimental generalized epilepsy.
    Mirski MA; Rossell LA; McPherson RW; Traystman RJ
    Anesthesiology; 1994 Dec; 81(6):1422-8. PubMed ID: 7992911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.